Print Page  Close Window

Investor Overview

Download Documentation Investor Presentation June 2017
Get help downloading or viewing the above file types

Corporate Profile

Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule oncology drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment.... More >>

Recent News

Calithera Biosciences to Participate in the JMP Securities 2017 Life Sciences Conference
Calithera Biosciences Announces FDA Fast Track Designation Granted to CB-839 for Treatment of Patients with Renal Cell Carcinoma
View More >>

In the Media

Download Documentation BioCentury- Triple Shot

Stock Quote

CALA (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Down 0.65 (4.10%)
Data as of 07/27/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
CALA (Common Stock)
Stock chart for: CALA.OQ.  Currently trading at $15.20 with a 52 week high of $20.05 and a 52 week low of $2.20.

Upcoming Events

There are currently no events scheduled.
View More >>
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources